Type of Study:
Adults 18 years and older with mild to moderate COVID-19 illness
Study Length:
12 weeks
Target Age/Sex:
18 years and older, Male and Female
Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: ClinicalTrials.gov
Staus: On Hold
Description:
The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.
LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed on site or by phone.
